Changes in antidiabetic medication cost sharing due to a value-based pharmacy access program led to increased use of generic and brand antidiabetic oral medications and insulin.
John J. Mahoney, MD
Advertisement
Articles by John J. Mahoney, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Halfway There Is Nowhere
2
CagriSema Outperforms Semaglutide in Lowering HbA1C, Reducing Weight Across REIMAGINE Trials
3
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
4
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
5